←Back to Expert Scholars
Translational Medicine / 转化医学Emerging Lung Targets
Thomas Stinchcombe
MD
🏢Duke Cancer Institute🌐USA
Professor of Medicine
55
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Thomas Stinchcombe is a senior thoracic oncologist at Duke who has led multiple cooperative group trials in NSCLC. His work has contributed to HER2 mutation recognition and ADC trial participation. He also studies elderly-specific lung cancer treatment strategies.
Share:
🧪Research Fields 研究领域
NSCLC trials
HER2 mutations
Targeted therapy
Elderly patients
Adjuvant therapy
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Thomas Stinchcombe 的研究动态
Follow Thomas Stinchcombe's research updates
留下邮箱，当我们发布与 Thomas Stinchcombe（Duke Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment